While it has been shown that downregulation of ANK3 is associated with poor prognosis in multiple cancers such as prostate, ovarian, lung and breast27, a recent study also described that increased ANK3 contributes to prostate cancer progression, implying that both up and down regulation of this gene can be important at different clinical stages28. This evidence concerns the gene ANK3 and prostate cancer.